Focal segmental glomerulosclerosis: pathogenesis and treatment.
Benchimol
Corinne
C
Department of Pediatrics, Mount Sinai School of Medicine, NewYork, NewYork 10029, USA. Corinne.benchimol@mssn.edu
D000818:Animals; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D016162:Genes, Wilms Tumor; D005923:Glomerulosclerosis, Focal Segmental / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000151:congenital / Q000235:genetics; D010956:Plasmapheresis; D012083:Renin / Q000235:genetics
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D012083:Renin; D009173:Mycophenolic Acid